These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 15077316

  • 1. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease.
    Ruzek MC, Jha S, Ledbetter S, Richards SM, Garman RD.
    Arthritis Rheum; 2004 Apr; 50(4):1319-31. PubMed ID: 15077316
    [Abstract] [Full Text] [Related]

  • 2. Animal models of scleroderma.
    Lakos G, Takagawa S, Varga J.
    Methods Mol Med; 2004 Apr; 102():377-93. PubMed ID: 15286396
    [Abstract] [Full Text] [Related]

  • 3. Mast cells in murine graft-versus-host disease: a model of immunologically induced fibrosis.
    Choi KL, Claman HN.
    Immunol Ser; 1989 Apr; 46():641-51. PubMed ID: 2488873
    [No Abstract] [Full Text] [Related]

  • 4. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
    Bhattacharyya S, Ghosh AK, Pannu J, Mori Y, Takagawa S, Chen G, Trojanowska M, Gilliam AC, Varga J.
    Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
    [Abstract] [Full Text] [Related]

  • 5. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma.
    McCormick LL, Zhang Y, Tootell E, Gilliam AC.
    J Immunol; 1999 Nov 15; 163(10):5693-9. PubMed ID: 10553100
    [Abstract] [Full Text] [Related]

  • 6. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
    Sato S, Fujimoto M, Hasegawa M, Takehara K, Tedder TF.
    Mol Immunol; 2004 Nov 15; 41(12):1123-33. PubMed ID: 15482848
    [Abstract] [Full Text] [Related]

  • 7. Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride.
    Christner PJ, Artlett CM, Conway RF, Jiménez SA.
    Arthritis Rheum; 2000 Nov 15; 43(11):2598-605. PubMed ID: 11083286
    [Abstract] [Full Text] [Related]

  • 8. Is graft-versus-host disease a reliable model for scleroderma?
    Mekori YA, Claman HN.
    Ric Clin Lab; 1986 Nov 15; 16(4):509-13. PubMed ID: 3576048
    [Abstract] [Full Text] [Related]

  • 9. The immunobiology of systemic sclerosis.
    Gu YS, Kong J, Cheema GS, Keen CL, Wick G, Gershwin ME.
    Semin Arthritis Rheum; 2008 Oct 15; 38(2):132-60. PubMed ID: 18221988
    [Abstract] [Full Text] [Related]

  • 10. Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse.
    Servettaz A, Goulvestre C, Kavian N, Nicco C, Guilpain P, Chéreau C, Vuiblet V, Guillevin L, Mouthon L, Weill B, Batteux F.
    J Immunol; 2009 May 01; 182(9):5855-64. PubMed ID: 19380834
    [Abstract] [Full Text] [Related]

  • 11. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
    Yamamoto T, Takahashi Y, Takagawa S, Katayama I, Nishioka K.
    J Rheumatol; 1999 Dec 01; 26(12):2628-34. PubMed ID: 10606374
    [Abstract] [Full Text] [Related]

  • 12. Immunological basis of systemic sclerosis.
    Zuber JP, Spertini F.
    Rheumatology (Oxford); 2006 Oct 01; 45 Suppl 3():iii23-5. PubMed ID: 16987826
    [Abstract] [Full Text] [Related]

  • 13. B cells in systemic sclerosis: a possible target for therapy.
    Bosello S, De Luca G, Tolusso B, Lama G, Angelucci C, Sica G, Ferraccioli G.
    Autoimmun Rev; 2011 Aug 01; 10(10):624-30. PubMed ID: 21545850
    [Abstract] [Full Text] [Related]

  • 14. Animal model of systemic sclerosis.
    Yamamoto T.
    J Dermatol; 2010 Jan 01; 37(1):26-41. PubMed ID: 20175838
    [Abstract] [Full Text] [Related]

  • 15. SKL-2841, a dual antagonist of MCP-1 and MIP-1 beta, prevents bleomycin-induced skin sclerosis in mice.
    Kimura M, Kawahito Y, Hamaguchi M, Nakamura T, Okamoto M, Matsumoto Y, Endo H, Yamamoto A, Ishino H, Wada M, Omoto A, Tsubouchi Y, Kohno M, Yoshikawa T.
    Biomed Pharmacother; 2007 May 01; 61(4):222-8. PubMed ID: 17147981
    [Abstract] [Full Text] [Related]

  • 16. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
    Kim W, Kim J, Jung D, Kim H, Choi HJ, Cho HR, Kwon B.
    Biol Blood Marrow Transplant; 2009 Mar 01; 15(3):306-14. PubMed ID: 19203721
    [Abstract] [Full Text] [Related]

  • 17. Cellular and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective.
    Yamamoto T, Nishioka K.
    Exp Dermatol; 2005 Feb 01; 14(2):81-95. PubMed ID: 15679577
    [Abstract] [Full Text] [Related]

  • 18. Allograft inflammatory factor-1 is overexpressed and induces fibroblast chemotaxis in the skin of sclerodermatous GVHD in a murine model.
    Yamamoto A, Ashihara E, Nakagawa Y, Obayashi H, Ohta M, Hara H, Adachi T, Seno T, Kadoya M, Hamaguchi M, Ishino H, Kohno M, Maekawa T, Kawahito Y.
    Immunol Lett; 2011 Mar 30; 135(1-2):144-50. PubMed ID: 21040744
    [Abstract] [Full Text] [Related]

  • 19. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
    Distler JH, Jüngel A, Pileckyte M, Zwerina J, Michel BA, Gay RE, Kowal-Bielecka O, Matucci-Cerinic M, Schett G, Marti HH, Gay S, Distler O.
    Arthritis Rheum; 2007 Dec 30; 56(12):4203-15. PubMed ID: 18050252
    [Abstract] [Full Text] [Related]

  • 20. Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis.
    Avouac J, Fürnrohr BG, Tomcik M, Palumbo K, Zerr P, Horn A, Dees C, Akhmetshina A, Beyer C, Distler O, Schett G, Allanore Y, Distler JH.
    Arthritis Rheum; 2011 Mar 30; 63(3):800-9. PubMed ID: 21360510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.